Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GVK Biosciences (GVK BIO), an India-based contract research organisation, has opened a new clinical pharmacology unit (CPU) in Ahmedabad, India. The Ahmedabad CPU, which will conduct a variety of studies in healthy volunteers, adds 110 beds to GVK’s existing capacity of 144 beds.
Subscribe to our email newsletter
Key features of the unit include access to special population like young women, post-menopausal women, diseased population and access to about 12,000 healthy volunteers.
GVK BIO’s Clinical Pharmacology Unit, operational from 2004 in Hyderabad, has undergone several international audits, inspections and has key accreditations to its credit including the USFDA, DCG(I), ANVISA (Brazil), AFSSAPS (France), WHO and the Ministry of Health, Turkey.
In addition to the healthy volunteer population, the Ahmedabad facility gives access to diseased population in Psychiatry, Metabolism, Cardiovascular, Neurology etc.
Manni Kantipudi, president of GVK Biosciences, said: “The opening of the new GVK Clinical Pharmacology unit reflects our commitment to offer faster recruitment solutions to our customers. The facility has been audited by the DCGI and we have initiated our first study at the Ahmedabad facility.”